Tze Min Wah
Papers
2
Total Citations
32
H-Index
2
About
Tze Min Wah is a pioneering interventional radiologist whose work is reshaping the landscape of non-invasive cancer treatment. Her research centers on image-guided tumor ablation, with a particular focus on histotripsy—a revolutionary, non-thermal, non-invasive focused ultrasound technology that mechanically liquefies tissue. Dr. Wah leads the landmark **#HOPE4LIVER** single-arm pivotal trial, which evaluates the 1-year clinical outcomes of hepatic histotripsy for primary and metastatic liver tumors (2025, 30 citations). This work represents a paradigm shift, offering a scarless, radiation-free alternative to traditional surgery or thermal ablation. Beyond the liver, she addresses critical clinical dilemmas in renal oncology, such as the management of incidental small renal masses in solitary kidneys, providing evidence-based guidance for curative-intent treatment. With a career dedicated to advancing minimally invasive therapies, Dr. Wah’s contributions are defining the future of interventional oncology, translating cutting-edge physics into tangible patient benefits. Her high-impact trials are not only setting new standards of care but are also inspiring a generation of researchers to explore the frontiers of non-invasive tumor destruction.
Research Focus
Key Achievements
Top Papers
- 1
- 2